![Clin Asst Prof Chua Lee Min Kevin, [object Object]](/_next/image?url=https%3A%2F%2Fd3fzwscyjtgllx.cloudfront.net%2Fuploads%2Fimages%2F625916997425983578424.jpg&w=3840&q=60)
Clin Asst Prof Chua Lee Min Kevin
Senior Consultant
Consults at:
Surgeries
N/A
Experience
N/A years
FAQs
Dr. Chua is a Senior Consultant in Radiation Oncology, specializing in Neuro-Oncology and Thoracic-Oncology.
Senior Consultant
Consults at:
Dr Kevin Chua, a clinician investigator in the Precision Radiation Oncology Programme, earned his medical degree with distinction from King’s College London School of Medicine. As a recipient of the Health Manpower Development Plan fellowship award, he completed fellowships in clinical oncology at the University College London Hospital and National Hospital for Neurology and Neurosurgery.
He currently serves as co-chair of the neuro-oncology service and leads the stereotactic radiosurgery service for the treatment of brain and spine metastases. In recognition of his efforts, he was awarded the Singapore Health Quality Service Award. He also serves on the Advanced Radiation Technology committee in the International Association for the Study of Lung Cancer (IASLC) and is an associate editor for the British Journal of Radiology.
Dr Chua's research interests lie in the discovery of biomarker signatures for radio-resistance, and his work has been published in high-impact journals including the International Journal of Radiation Oncology, Biology, Physics, Journal of Thoracic Oncology, Annals of Oncology and JAMA Oncology. His work has been presented at esteemed international scientific meetings such as the International Stereotactic Radiosurgery Society (ISRS), American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), Wolfsburg Meeting on Molecular Radiation Biology/ Oncology and American Society for Radiation Oncology (ASTRO).
Notably, Dr Chua received the Conquer Cancer Foundation ASCO Merit Award in recognition of his top-ranked abstract on his work profiling the systemic immune landscape following radiotherapy.
